In the development of MM, the NF-κB and PI3K-AKT-mTOR signaling pathways are activated, which induce bone marrow stromal cells to secrete abundant IL-6 and growth factors, contributing to the growth, proliferation and survival of myeloma cells. Here, MTOR is linked to Miyoshi myopathy.